Atlas Trials

Study to Assess the Safety and Tolerability of MBF-118 in Healthy Volunteers

Clinical trial NCT05921916 · COMPLETED

Trial details

NCT number
NCT05921916
Sponsor
Medibiofarma S.L.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cancer
Start date
2020-07-03
Primary completion
2022-09-06
Enrollment
56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.